Q4 2024 Holdings
Filed 2025-02-14 | 12 holdings | $592.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $272.3M | 10,597,181 | 46.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $128.7M | 5,462,846 | 21.7% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $64.1M | 9,632,561 | 10.8% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $48.3M | 3,452,330 | 8.2% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $48.1M | 3,970,668 | 8.1% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $25.7M | 2,872,537 | 4.3% |
| Achilles Therapeutics PLC(698) | SPONSORED ADS | 00449L102 | $2.7M | 2,390,050 | 0.5% |
| Engene Holdings Inc(ENGNW) | W EXP 10/31/2028 | 29286M113 | $2.4M | 2,878,148 | 0.4% |